| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,286,692 |
| 52
Week Range: |
$0.92 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcgahan Keith M |
SVP and Chief Legal Officer |
• – – |
2019-05-14 |
4 |
AS |
$8.82 |
$4,041 |
D/D |
(458) |
139,291 |
|
- |
|
| Vacirca Jeff L |
Director |
– • – |
2019-05-13 |
4 |
A |
$8.93 |
$8,930 |
D/D |
1,000 |
21,967 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2019-04-11 |
4 |
AS |
$10.75 |
$177,341 |
D/D |
(16,493) |
260,423 |
|
- |
|
| Mcgahan Keith M |
SVP and Chief Legal Officer |
• – – |
2019-04-11 |
4 |
AS |
$10.67 |
$21,532 |
D/D |
(2,018) |
139,749 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-04-11 |
4 |
AS |
$10.67 |
$114,574 |
D/D |
(10,738) |
22,250 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2019-04-02 |
4 |
AS |
$10.57 |
$19,887 |
D/D |
(1,882) |
276,988 |
|
- |
|
| Mcgahan Keith M |
SVP and Chief Legal Officer |
• – – |
2019-04-02 |
4 |
AS |
$10.57 |
$19,126 |
D/D |
(1,810) |
141,767 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-04-01 |
4 |
AS |
$10.73 |
$49,940 |
D/D |
(4,642) |
236,098 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-03-29 |
4 |
AS |
$10.65 |
$63,623 |
D/D |
(5,974) |
240,740 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2019-03-29 |
4 |
AS |
$10.65 |
$67,170 |
D/D |
(6,307) |
471,919 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-03-26 |
4 |
AS |
$9.90 |
$9,167 |
D/D |
(926) |
246,714 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-03-25 |
4 |
AS |
$9.46 |
$35,931 |
D/D |
(3,797) |
247,640 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2019-03-25 |
4 |
AS |
$9.46 |
$50,296 |
D/D |
(5,315) |
478,226 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-03-21 |
4 |
AS |
$10.00 |
$55,000 |
D/D |
(5,500) |
32,988 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-03-21 |
4 |
OE |
$5.05 |
$27,775 |
D/D |
5,500 |
38,488 |
|
- |
|
| Vacirca Jeff L |
Director |
– • – |
2019-03-18 |
4 |
A |
$10.47 |
$20,940 |
D/D |
2,000 |
20,967 |
|
- |
|
| Cohen Raymond W |
Director |
– • – |
2019-03-15 |
4 |
A |
$9.59 |
$47,950 |
D/D |
5,000 |
43,850 |
|
- |
|
| Vacirca Jeff L |
Director |
– • – |
2019-03-15 |
4 |
A |
$9.62 |
$19,240 |
D/D |
2,000 |
18,967 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-02-21 |
4 |
AS |
$11.63 |
$63,965 |
D/D |
(5,500) |
32,988 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2019-02-21 |
4 |
OE |
$5.05 |
$27,775 |
D/D |
5,500 |
38,488 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2019-02-20 |
4 |
AS |
$11.47 |
$26,218 |
D/D |
(2,285) |
278,808 |
|
- |
|
| Mcgahan Keith M |
SVP and Chief Legal Officer |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
143,577 |
|
- |
|
| Turgeon Joseph W. |
CEO & President |
• • – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
483,541 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
256,896 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
281,083 |
|
- |
|
658 Records found
|
|
Page 9 of 27 |
|
|
